# A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

> **NCT05495906** · PHASE4 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 275 (estimated)

## Conditions studied

- HPV
- Human Papilloma Virus
- Human Immunodeficiency Virus

## Interventions

- **BIOLOGICAL:** Nonavalent HPV vaccine

## Key facts

- **NCT ID:** NCT05495906
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-27
- **Primary completion:** 2026-08
- **Final completion:** 2028-01
- **Target enrollment:** 275 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05495906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05495906, "A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05495906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*